ABSTRACT
InTRoduCTIon
The management and the effectiveness of the surgical treatment of spontaneous intracerebral hematoma (ICH) are still controversial. There is no clear indication of the optimal treatment choice for ICH; surgical or otherwise. Current clinical practice seems varied. Proper evaluation of the role of surgery on spontaneous ICH should be provided (8, 29) . In fact, 18 randomized trials ( (17) , revealed no benefit from surgical treatment. This study had a strong influence on neurosurgical practice, even nowadays (8) . Studies by Juvela et al (14) in 1989, Batjer et al (2) in 1990, Morgenstren et al (21) in 1998, Zuccarello et al (28) , Kurtsoy et al (15) and Miller et al (19) were all too small in number of patients to be conclusive. Auer et al (1) in 1989 found a significant benefit from endoscopic To investigate the feasibility of surgical treatment of ICH, we analyzed and reviewed eighteen randomized studies on surgical treatment versus current non-operative management in patients with spontaneous supratentorial ICH.
MATERIAL and METHodS
A literature search was performed using PUBMED, MEDLINE, EMBASE-Excerpta Medica databases from 1960 to 2010 on randomized studies for the treatment of spontaneous ICH. Reference lists of all the articles identified were also examined, and relevant cited references were similarly reviewed. Eighteen randomized prospective studies between the years 1960-2010 were included. All available data were then combined to be analyzed as a whole.
The summaries of the studies are given in Table I .
Statistical analysis was performed via the computer-based software SPSS 16.0 and NCSS for windows.
Simple descriptives were used for total, minimum and maximum number of centers and number of patients (surgical, medical, totally) and age while simple descriptives and frequencies were used for administration time and surgical time.
Age was divided into two groups as below and above 65 years of age.
Admission and surgical time were evaluated in two groups as before and after 24 hours.
Hematoma dimensions were given as volume and/or diameter and/or depth, and the distribution among studies was analyzed by simple descriptives.
ICH volume was grouped into four groups: group 1: <10ml, group 2:10-40ml, group 3:40-80ml and group 4:>80ml.
Glasgow Coma Scale (GCS) was evaluated in 4 groups; Group 1 (3-5): very severe Group 2 (6-8): severe Group 3 (9-12): moderate Group 4 (13-15):mild All available data from included studies were entered and combined to be analyzed as a whole by using the wellestablished meta-analysis methods. Using the end points of death and dependency, the results were expressed as odds ratios with their associated 95% confidence intervals. Significance was assigned at a p value <0.05
RESuLTS
An elegant description of the relevant details of the previously meta-analyzed trials is already available and will not be repeated here.
All included studies are summarized in Table I .
In this meta-analysis we analyzed all parameters of 18 studies.
Among 18 studies 7 (38.9%) were multicenter, 11 (61.1%) were single center. A total of 204 centers participation was included.
A total of 5511 patients were involved in 18 studies; the minimum number of total patients in a study was 10, and the maximum was 1578. In the study by Gregson et al (11) on 542 patients, neurosurgeons were not sure of the treatment which mostly appropriate treatment and/or informed consent could not be obtained. Those patients were excluded and the final total number of patients was 4969. 1769 patients were treated surgically and 3200 medically (Table II) .
The admission time was reported in 10 studies . Among these studies, admission time was the first 6 hours in 1 (10%), the first 12 hours in 2 (20%), the first 24 hours in 5 (50%) and the first 72 hours in 2 (20%) ( Table III) .
Age range of all studies was 15 to 80 years with a mean of 64.2±15.5 years.
Hematoma location was supratentorial in all studies. Hematoma dimensions were given as volume and/or diameter. Hematoma volume distribution among eleven studies was 10 to 100 cm3. In four studies mean hematoma volume was used; minimum 40 cm3 and maximum 96 cm3. In four studies hematoma diameter was used; minimum 2cm, maximum 5cm. Hematoma depth was given in three studies, among these the range was 1-2cm.
Surgery time was reported in 15 studies. In the study Sun DTF et al (26) surgical time was evaluated in two groups as early (before 24 hours) and late surgery (after 24 hours). Thus 16 surgical time results were present in 15 studies; surgery time was within 3 hours of submission in 1 (6.25), within 6 hours in 1 (6.25%), within 12 hours in 2 (12.5%), before 24 hours in 5 (31.25%), after 24 hours in 2 (12.5%), within 48 hours in=3 (18.75%) and within 72 hours in=2 (12.5%) (Table IV) .
Surgical type was reported in 17 studies. The types of surgery are given in Table V . Craniotomy was the most preferred method (n=14; 77.8%). In three studies two types (craniotomy and stereotactic in both, stereotactic and stereotactic plus fibrinolytic in one), in two studies three types (craniotomy, stereotactic surgery, EVD) and in one study four types (craniotomy, stereotactic, endoscopic, simple aspiration with burr-hole) of surgical procedures were used.
Follow-up time was given in 14 studies, varied 1-24months and preferred, mostly at 6 months (n=9).
Meta-analysis of the effect of surgical versus medical treatment on outcome (mortality/morbidity) after a supratentorial spontaneous ICH indicate a nonsignificant increase (p=0.822) in the odds (0.92) of death and dependency at 6 months for patients treated surgically (Table VI) .
Subgroup analyses were carried out for the effect of admission time, age, hematoma volume, surgical time and GCS on mortality and morbidity. Admission time, age factor did not make a significant effect on mortality or morbidity. In cases with hematoma volume >40ml, surgical treatment results were significantly better regarding mortality (p=0.04) and morbidity (p=0.019). Early surgery (before 24 hours) favours the outcome regarding morbidity significantly (p=0.01) and mortality but insignificantly (p=0.075). The endoscopic approach yielded a better outcome for morbidity (p=0.048).
In cases with GCS≥6, surgical results were found to be better for mortality (p=0.035) and for morbidity (p=0.044).
dISCuSSIon
There is still debate among neurosurgeons and neurologist all over the world on the effective treatment of intracerebral hematoma (ICH) and about whether it should be surgically or medically treated. Criterias on treatment decision include; patient's age, hematoma volume, location and deepness from the surface, Glasgow coma scale (GCS), pathologies underlying hematoma (aneurysm, AVM, trauma etc.), time duration between hemorrhage and diagnosis, severe coagulopathy or presence of underlying serious medical disease, progression on neurological deficits or conscious, development of obstructive hydrocephaly, and compression of brain stem (3, 8, 9) . However, The STICH (surgical treatment for intracerebral haemorrhage) study showed no overall benefit from early surgery when compared with initial conservative treatment (25) .
The aim of surgical treatment in ICH can be summarized briefly as 'removing the most hematoma volume in the fastest way and with minimum surgical damage as possible' . If there is an underlying pathology of the hematoma, intervention should also be performed to that lesion during the surgery (3, 8, 9) .
The percentage of preferring surgery changes in different countries. There are severe differences of surgical rates among countries and this can be attributed to the difference of patients' admission, to the difference of decision criteria among clinics, to the difference of centers' structure, to the difference of surgical expertise among countries and to the difference of people's expectations among countries. (11, 26) Surgical indication criterion of supratentorial hematomas include; progressive deterioration of consciousness, increased edema on CT, determining AVM, aneurysm or tumor on MRI and angiography, development of obstructive hydrocephalus, compression on brain stem, shift effect, patient age less than 80, GCS of 5-11, lack of severe coagulopathy or presence of systemic disease, hematoma volume greater than 30 cm3 at cerebral and diameter greater than 3 cm at cerebellar region, hematoma location on non-dominant hemisphere, lobar and external capsule (1,4,6,7,11,13,14,19,22,23,26,2 7,29) . In Broderick et al's study (3) surgical treatment was recommended for cases with low GCS, lobar hematoma, hematoma near surface and wide hematoma.
A medical approach is preferred for the patients with; hematoma volume ≤ 10 cm3 or ≥ 60 cm3 in supratentorial hemorrhage or for cases demonstrating minimal neurological deficit, in cases that would have very good or very poor prognosis, who have GCS greater than 10 or GCS less than five respectively or extravasation of contrast medium at hematoma area on CT, for cases with severe coagulopathy or presence of underlying serious medical disease, for very old (over 80) cases that would not tolerate operation and for pontine hematomas which are 60% fatal (4, 7, 17, 26) Surgical methods includes; simple aspiration (with Burr-hole), open craniotomy, decompression and removal of hematoma, fibrinolytic treatment, stereotactic surgery with fibrinolytic treatment, neuroendoscopic surgery with fibrinolytic treatment and stereotactic endoscopic removal (1,4,6,7,11,1 3,14,19,22,23,26,27,29) . In contrast, the stereotactic aspiration technique can be safely performed and in a uniform manner. Despite the reduction of ICH volume, no improvement in mortality and functional result was obtained. Endoscopy is a new therapeutic option for ICH with good results for hematoma removal (7, 19, 25) Timing of surgery is important. Early surgery decreases the toxic effects of blood and plasma products and this provides decrease of ischemia and edema of the neighboring glial tissues. Hematoma reaches its maximum dimensions in the first six hours (10) . However very early surgery increases new hemorrhage risk. New hemorrhage risk after surgery is reported to be 40% in 4 hours and 12% in 12 hours by Morganstern et al (20) , and 22% in 3-5 and 9% in 6-8 by Pantazis et al (23) .
Simple aspiration by Burr-hole can be used in emergent cases. It can be performed by local anesthesia. Technically aspiration is performed after placing a catheter into hematoma but it is not preferred nowadays. Only a small volume of hematoma can be aspirated. It can cause new hemorrhage since aspiration is performed in a blind way (18) .
Craniotomy is a standard approach. It can be performed with decompressive craniectomy and duraplasty. It allows intervention to underlying pathology of hematoma. Adequate amount of hematoma can be aspirated. Bleeding control is easy (2, 14, 17, 21, 23, 24, 29) .
Fibrinolytic treatment dissolves the blood rapidly and draining or aspiration. Fibrinolytic agents that can be used are urokinase and tissue fibrinogen activator (rTPA). Urokinase is applied as 5000-10000U in 5ml saline solution 1 to 4 times a day, treatment should be continued for 7 or more days. rTPA is applied as 2mg/12hours for 2-4 days or 5mg/24hours for 2-4 days. Fibrinolytic treatment increases new hemorrhage risk (13, 27) In stereotactic surgery, a silicon catheter is placed in hematoma location by stereotactic method. Initially the technique was only used for aspiration, recently it is used with fibrinolytic treatment. It can be performed under local anesthesia. Catheter is placed in the center of the hematoma (13, 27) .
Neuroendoscopic surgery is used for especially putaminal and thalamic wide hematomas (5, 7) . Under general anesthesia burr-holes from both frontal regions are performed, hematoma is aspirated through ventricle. Endoscope also can be replaced by stereotactic frame. It can also be performed as endoscopic aspiration of the hematoma through a study canule passing the opening of single burr-hole from the ipsilateral side. (5,7) . Third ventriculostomy can be performed. Both lateral ventricle atria, frontal horns and third ventricle can be aspirated. Sometimes with 30º telescopes temporal horns and forth ventricle can be seen (28). The results of the randomized studies we included in our analysis revealed in 18 studies (1,2,4,6,7,11,13,14,15,17,1 8,19,22,23,24,26,27,29) overall no significance was found among surgical and medical studies. Only in two studies by Kurtsoy A et al (15) and Miller et al (19) was mortality found to be significantly lower in the operated group than the nonoperated group, although the number of included patients was limited (21 surgically, 24 medically treated in Kurtsoy's (15) and 6 surgically, 4 medically treated in Miller's studies). The most striking differences of Kurtsoy's (15) study from others are firstly the surgical technique, contralateral transcallosal microsurgical approach, in very early stage (within 6 hours), the second is the short admission time criteria (within 6 hours) and the third is they only included patients with moderate and severe thalamic hematomas with brainstem reflexes with GCS≥5. Miller et al (19) used stereotactic hematoma evacuation technique.
When we further analyze the results we found out that in two studies (4, 17) in general and in one study (26) only for ICH< 30 mL, medical treatment was reported to be insignificantly superior. Surgery results seemed better overall in the early period of two studies (21,29) but later no difference was found (21) . A significant ICH volume reduction was achieved by the intervention (27) . Surgical treatment results were found to be superior to medical treatment results in subcortical (1, 23, 24, 26) , putaminal (22, 23, 26) right sided (24) , lobar (24) hematomas, in large hematoma volume (>5cm diameter or >50ml volume) (22, 24, 26) , in hematomas that caused a big shift (24) and in patients with moderate GCS (7, 14, 23) . Early surgery improves surgical results, thus to be preferred (15, 24, 26) .
The studies reporting medical treatment is advantageous over surgical reveal:
-No significance among the treatment groups, but a higher chance of death or dependency with surgery (17) -At 1st month the medical group showed significantly higher rate of outcomes, however no differences between the groups are reported at 3 months, a trend toward a higher chance of death or dependency with surgery (4) -For ICH< 30 mL, conservative management is superior (26) The studies reporting surgical treatment is advantageous over medical reveal:
-No significance on mortality and recovery rates of putaminal and thalamic hematomas but surgical treatment results were better in subcortical hematoma.
-Mortality rate, among cases with GCS 7-10 was significantly lower in the surgical treatment group than in the medical.
-Mortality was seemed to be lower in the surgical group compared with the medical group at 1st month, but similar at 6th months (21) -Analysis of the secondary 3-month outcome measures showed a nonsignificant trend toward a better outcome in the surgical versus medical for the median GOS, Barthel Index, and Rankin Scale and a significant difference in the National Institutes of Health Stroke Scale score (7, 13, 29) -A significant ICH volume reduction was achieved by the intervention (7, 19, 27) -Early surgery in patients with putaminal and subcortical haematomas with ICH> 50 ml is superior (6, 22, 23, 26) -Surgery was to be preferred when ICH had these features: Right side, lobar location, superficial, large volume, big shift, and early diagnosed and treated patients (23, 24, 26) -In hematomas >5cm the surgical treatment results were significantly better (22, 23) The main question to be answered is which cases we should operate?
Fewel et al (9) suggested that surgery should be considered in patients with moderate to large lobar or basal ganglia hemorrhages and those suffering progressive neurological deterioration, Proust et al (25) suggested supratentorial craniotomy for patients with GCS>8, HC volume of 10-40ml, lobar or for hematomas located at about 1cm to cortical surface.
According to our meta-analysis results patients with the GCS score ≥ 6, and those with hematoma volume greater than 40ml benefit from surgery.
The second question is which surgical technique we should choose?
According to Zuccarello et al (29) removed hematoma volume in craniotomy group is greater than stereotactic group. According to Morioka J (22) there is no significant difference between craniotomy and stereotactic operation on patients last state. Craniotomy has the longest operation time. Blood loss is reported to be most significant in the craniotomy. The highest hematoma evacuation rate was seen in the endoscopic surgery (5, 7) . In Cho's study (5) the mortality rate was 0%, 6.7% and 13.3% and the complication rate was 3.3%, 10% and 16.6% in endoscopic aspiration surgery group, in stereotactic aspiration and fibrinolytic treatment group, and in craniotomy group respectively. Both endoscopic surgery and stereotactic aspiration are minimally invasive and are effective procedures with low complication and mortality rates; however, the waiting timing of stereotactic aspiration is usually longer. Endoscopic surgery may be an appropriate substitute for stereotactic aspiration. It produces good neurological outcomes and aids in rapid hematoma. (5, 7, 19) . In 18 studies we analyzed, only in Kurtsoy A et al's (15) and Miller's et al (19) studies mortality was found significantly lower in the operated group than the nonoperated group. The surgical technique was contralateral transcallosal microsurgical approach and endoscopic evacuation respectively (15, 19) . However according to our meta-analysis the studies are not enough to analyze the best surgical type.
